Inflammatory Bowel Disease Cohort in Nantes
Recruiting · NCT06256393 · Observational (researchers observe without assigning treatment) · Lead sponsor: Nantes University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Collection of biological samples
What this trial is about
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients over 18 years of age;
- Patients with an established diagnosis of IBD: CD, UC, unclassified IBD or refractory chronic pouchitis;
- Patients with active disease requiring surgery or endoscopy, whether performed at diagnosis or prior to initiation of new therapy;
- Patients who have given written consent to participate in the study and to keep biological samples for research purposes
Exclusion criteria
- Patients refusing to participate in the cohort;
- Patients with chronic inflammatory bowel disease quiescent at inclusion;
- Patients with a contraindication to general anaesthesia;
- Vulnerable patients (under court protection, curators, guardians);
Where it is running
6 locations listed.
- CHU de Nantes - Nantes, France
- Clinique Jules Verne - Nantes, France
- Hopital Privé du Confluent - Nantes, France
- CHU de Nantes - Nantes, France
- Clinique Jules Verne - Nantes, France
- Hopital Privé du Confluent - Nantes, France